Detalhe da pesquisa
1.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
N Engl J Med
; 388(25): 2338-2348, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37342922
2.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(5): 503-513, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156478
3.
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy.
Am J Hematol
; 97(9): 1170-1177, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731911
4.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
J Natl Compr Canc Netw
; 19(1): 16-27, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406488
5.
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(6): 721-749, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200351
6.
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(7): 926-957, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687581
7.
New methods for assessing response in acute myeloid leukemia.
Curr Opin Hematol
; 22(2): 132-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584823
8.
Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations.
JCO Oncol Pract
; 20(4): 538-548, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38241601
9.
Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomes.
Patient Educ Couns
; 123: 108177, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341898
10.
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial.
Transplant Cell Ther
; 29(6): 358.e1-358.e7, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840087
11.
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
Lancet Haematol
; 10(11): e890-e901, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776872
12.
Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failure.
Leuk Res Rep
; 17: 100302, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35360511
13.
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
Leuk Lymphoma
; 62(1): 158-166, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32951486
14.
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
Transplant Cell Ther
; 27(11): 923.e1-923.e12, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34428556
15.
Splenic Lymphomas Presenting as Splenomegaly.
Oncology (Williston Park)
; 29(6): 427-8, 441, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26091676
16.
HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals.
J Oncol Pract
; 11(3): e336-50, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736385
17.
The role of vitamin D in hematologic disease and stem cell transplantation.
Nutrients
; 5(6): 2206-21, 2013 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23778150